SARS-CoV-2 在患有非霍奇金淋巴瘤的免疫功能低下患者中的长期进化。

Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma.

机构信息

Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge (INSA), Lisbon, Portugal.

Clinical Pathology-Virology Lab, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal.

出版信息

mSphere. 2021 Aug 25;6(4):e0024421. doi: 10.1128/mSphere.00244-21. Epub 2021 Jul 28.

Abstract

Recent studies have shown that persistent SARS-CoV-2 infections in immunocompromised patients can trigger the accumulation of an unusual high number of mutations with potential relevance at both biological and epidemiological levels. Here, we report a case of an immunocompromised patient (non-Hodgkin lymphoma patient under immunosuppressive therapy) with a persistent SARS-CoV-2 infection (marked by intermittent positivity) over at least 6 months. Viral genome sequencing was performed at days 1, 164, and 171 to evaluate SARS-CoV-2 evolution. Among the 15 single-nucleotide polymorphisms (SNPs) (11 leading to amino acid alterations) and 3 deletions accumulated during this long-term infection, four amino acid changes (V3G, S50L, N87S, and A222V) and two deletions (18-30del and 141-144del) occurred in the virus Spike protein. Although no convalescent plasma therapy was administered, some of the detected mutations have been independently reported in other chronically infected individuals, which supports a scenario of convergent adaptive evolution. This study shows that it is of the utmost relevance to monitor the SARS-CoV-2 evolution in immunocompromised individuals, not only to identify novel potentially adaptive mutations, but also to mitigate the risk of introducing "hyper-evolved" variants in the community. Tracking the within-patient evolution of SARS-CoV-2 is key to understanding how this pandemic virus shapes its genome toward immune evasion and survival. In the present study, by monitoring a long-term COVID-19 immunocompromised patient, we observed the concurrent emergence of mutations potentially associated with immune evasion and/or enhanced transmission, mostly targeting the SARS-CoV-2 key host-interacting protein and antigen. These findings show that the frequent oscillation in the immune status in immunocompromised individuals can trigger an accelerated virus evolution, thus consolidating this study model as an accelerated pathway to better understand SARS-CoV-2 adaptive traits and anticipate the emergence of variants of concern.

摘要

最近的研究表明,在免疫功能低下的患者中持续性的 SARS-CoV-2 感染会导致大量异常突变的积累,这些突变在生物学和流行病学水平上都具有潜在的相关性。在这里,我们报告了一例免疫功能低下的患者(接受免疫抑制治疗的非霍奇金淋巴瘤患者)持续性 SARS-CoV-2 感染(间歇性阳性)至少 6 个月。在第 1、164 和 171 天进行了病毒基因组测序,以评估 SARS-CoV-2 的进化。在长期感染过程中,积累了 15 个单核苷酸多态性(SNP)(其中 11 个导致氨基酸改变)和 3 个缺失,在病毒 Spike 蛋白中,有 4 个氨基酸变化(V3G、S50L、N87S 和 A222V)和 2 个缺失(18-30del 和 141-144del)。虽然没有进行恢复期血浆治疗,但在其他慢性感染个体中也独立报道了一些检测到的突变,这支持了趋同适应性进化的情况。这项研究表明,监测免疫功能低下个体中的 SARS-CoV-2 进化非常重要,不仅要识别新的潜在适应性突变,还要降低在社区中引入“超进化”变异的风险。 跟踪 SARS-CoV-2 患者内的进化是了解这种大流行病毒如何针对免疫逃避和生存来塑造其基因组的关键。在本研究中,通过监测一名长期 COVID-19 免疫功能低下患者,我们观察到了与免疫逃避和/或增强传播相关的突变的同时出现,这些突变主要针对 SARS-CoV-2 的关键宿主相互作用蛋白和抗原。这些发现表明,免疫功能低下个体的免疫状态频繁波动会引发病毒的加速进化,从而巩固了本研究模型作为一种加速途径,可以更好地了解 SARS-CoV-2 的适应性特征,并预测关注变体的出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbb9/8386466/e62caadb78eb/msphere.00244-21-f001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索